Clinical trials in Pula

Multiple innovative trials focusing on non-small cell lung cancer treatments, particularly evaluating combination therapies and new approaches for metastatic cases.

• Advanced treatment combinations
• Metastatic NSCLC therapy
• PD-1/PD-L1 inhibitor studies

Research aims to improve outcomes for patients who have progressed after standard treatments.

Clinical research examining new treatments for agitation in Alzheimer's dementia, testing innovative therapeutic approaches to manage behavioral symptoms.

• Behavioral symptom management
• Quality of life improvement
• Novel therapeutic compounds

Studies focus on enhancing patient care and reducing caregiver burden.

Groundbreaking research in early-stage breast cancer treatment, specifically targeting estrogen receptor-positive, HER2-negative cases with novel endocrine therapies.

• Targeted hormone therapy
• Adjuvant treatment optimization
• Personalized medicine approaches

Trials aim to improve treatment outcomes through targeted therapeutic strategies.

Important studies in cardiovascular disease prevention, evaluating new treatments for reducing major adverse cardiovascular events in high-risk patients.

• Primary prevention strategies
• Cardiovascular risk reduction
• Long-term outcome improvement

Research focuses on innovative preventive approaches for atherosclerotic cardiovascular disease.